- Genentech: Pegasys® (peginterferon alfa-2a) - Information for Patients
On February 18, 2021, zr pharma GmbH (“pharma ”) signed an agreement with F Hoffmann-La Roche Ltd to acquire the worldwide rights of Pegasys® (peginterferon alfa 2a) excluding China and Japan
- Pegasys: Uses, Dosage, Side Effects, Warnings - Drugs. com
Pegasys is made from human proteins that help the body fight viral infections Pegasys is used alone or with other medicines to treat chronic hepatitis C in adults and children at least 5 years old
- PEGASYS Prescribing Information - Genentech
PEGASYS monotherapy is only indicated for the treatment of patients with CHC and compensated liver disease if there are contraindications or significant intolerance to other HCV antiviral drugs
- Pegasys (Peginterferon alfa-2a): Side Effects, Uses, Dosage . . .
Before beginning PEGASYS or PEGASYS combination therapy, standard hematological and biochemical laboratory tests are recommended for all patients Pregnancy screening for women of childbearing potential must be performed
- Peginterferon alfa-2a Uses, Side Effects Warnings - Drugs. com
Brand names: Pegasys, Pegasys ProClick Autoinjector, Pegasys Prefilled Syringe Dosage form: subcutaneous solution (180 mcg 0 5 mL; 180 mcg mL) Drug class: Antiviral interferons Medically reviewed by Drugs com on Jul 4, 2025 Written by Cerner Multum Uses Side effects Warnings Before taking Dosage Interactions
- Pegasys (peginterferon alfa-2a): Uses, Side Effects . . . - WebMD
Find patient medical information for Pegasys (peginterferon alfa-2a) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings
- PRODUCT MONOGRAPH - Roche
Chronic Hepatitis B (CHB) PEGASYS is indicated for the treatment of both HBeAg-positive and HBeAg-negative chronic hepatitis B in: Patients with compensated liver disease, liver inflammation and evidence of viral replication (both cirrhotic and non-cirrhotic disease)
- DailyMed - PEGASYS- peginterferon alfa-2a injection, solution
PEGASYS (peginterferon alfa-2a) injection is a sterile, preservative-free, colorless to slightly yellowish solution administered subcutaneously Each PEGASYS Single-Dose Vial Package
|